Bain Capital announced today it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The acquisition values MTPC at approximately 510 billion JPY (3.3 billion USD) and is led by Bain Capital’s Private Equity teams in Asia and North America, along with its Life…